https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-30 / Cancer Immunol. Immunother. 2002 Apr;51(2):99-106
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-30 / Cancer Immunol. Immunother. 2002 Apr;51(2):99-1062002-01-30 00:00:002019-02-15 08:39:03Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-10 / Cancer Immunol. Immunother. 2002 Mar;51(1):45-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-10 / Cancer Immunol. Immunother. 2002 Mar;51(1):45-522002-01-10 00:00:002019-02-15 08:46:11Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-07 / Br. J. Cancer 2002 Jan;86(1):151-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-07 / Br. J. Cancer 2002 Jan;86(1):151-72002-01-07 00:00:002002-01-07 00:00:00Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-01 / Int J Gastrointest Cancer 2002;32(1):1-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-01 / Int J Gastrointest Cancer 2002;32(1):1-62002-01-01 00:00:002019-02-15 08:52:35The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-01 / Med. Oncol. 2002;19(4):213-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-01 / Med. Oncol. 2002;19(4):213-82002-01-01 00:00:002019-02-15 08:51:08Dendritic cell vaccines in the treatment of multiple myeloma: advances and limitations
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-01 / Surgery 2002 Jan;131(1 Suppl):S121-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-01 / Surgery 2002 Jan;131(1 Suppl):S121-72002-01-01 00:00:002019-02-15 09:17:55Hyperthermia for rectal cancer
